Forbes Medi-Technology rated strong buy (currently at $8.25)

1. Nasdaq listing expected any day now
2. Phytrol (cholesterol-reducing additive) to be in commercial production by end of June 2000
3. Forbes still talking to Cargill to ensure Forbes has a bigger share of the pie than what they had previously agreed to. This is in the interest of shareholders but many shareholders missed this crucial point and dumped the stock. Investology writers have taken this great opportunity to accumulate enough of FMI stock as our resources will permit. This stock is a great opportunity anywhere below $18
4. A number of brokerage houses - Loewen, Advest, Merrill, Dominion Securities, Cannaccord met with FMI management and agreed to support the stock price. I believe we have reached the bottom and expect the price to move up to the mid teens by Friday Jan 28/2000.
5. The fluffy press release which started the FMI stock price decimation was about the AD & ADD product which is just a gravy product for Forbes. Phytrol remains FMI's main product